83 FR 44892 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 171 (September 4, 2018)

Page Range		44892-44893
FR Document		2018-19074

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the internet at http:// www.samhsa.gov/workplace.

Federal Register, Volume 83 Issue 171 (Tuesday, September 4, 2018)

[Federal Register Volume 83, Number 171 (Tuesday, September 4, 2018)]
[Notices]
[Pages 44892-44893]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-19074]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the internet at http://www.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Charles LoDico, Division of Workplace 
Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N02C, Rockville, 
Maryland 20857; 240-276-2600 (voice).

SUPPLEMENTARY INFORMATION: The Department of Health and Human Services 
(HHS) notifies federal agencies of the laboratories and Instrumented 
Initial Testing Facilities (IITF) currently certified to meet the 
standards of the Mandatory Guidelines for Federal Workplace Drug 
Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were 
first published in the Federal Register on April 11, 1988 (53 FR 
11970), and subsequently revised in the Federal Register on June 9, 
1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 
(69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 
FR 75122); April 30, 2010 (75 FR 22809); and on January 23, 2017 (82 FR 
7920).
    The Mandatory Guidelines were initially developed in accordance 
with

[[Page 44893]]

Executive Order 12564 and section 503 of Public Law 100-71. The 
``Mandatory Guidelines for Federal Workplace Drug Testing Programs,'' 
as amended in the revisions listed above, requires strict standards 
that laboratories and IITFs must meet in order to conduct drug and 
specimen validity tests on urine specimens for federal agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified laboratory or IITF must 
have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA), 
which attests that it has met minimum standards.
    In accordance with the Mandatory Guidelines dated January 23, 2017 
(82 FR 7920), the following HHS-certified laboratories and IITFs meet 
the minimum standards to conduct drug and specimen validity tests on 
urine specimens:

HHS-Certified Instrumented Initial Testing Facilities

Dynacare, 6628 50th Street NW, Edmonton, AB Canada T6B 2N7, 780-784-
1190 (Formerly: Gamma-Dynacare Medical Laboratories).

HHS-Certified Laboratories

ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 
844-486-9226.
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-361-
8989/800-433-3823 (Formerly: Kroll Laboratory Specialists, Inc., 
Laboratory Specialists, Inc.).
Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 
804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., Scientific 
Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, 
Inc.).
Baptist Medical Center--Toxicology Laboratory, 11401 I-30, Little Rock, 
AR 72209-7056, 501-202-2783 (Formerly: Forensic Toxicology Laboratory 
Baptist Medical Center).
Clinical Reference Laboratory, Inc., 8433 Quivira Road, Lenexa, KS 
66215-2802, 800-445-6917.
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800-
235-4890.
Dynacare,* 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679-
1630 (Formerly: Gamma-Dynacare Medical Laboratories).
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 
662-236-2609.
Laboratory Corporation of America Holdings, 7207 N Gessner Road, 
Houston, TX 77040, 713-856-8288/800-800-2387.
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 
08869, 908-526-2400/800-437-4986 (Formerly: Roche Biomedical 
Laboratories, Inc.).
Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, 
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984 (Formerly: 
LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, 
Inc.; CompuChem Laboratories, Inc., a Subsidiary of Roche Biomedical 
Laboratory; Roche CompuChem Laboratories, Inc., a Member of the Roche 
Group).
Laboratory Corporation of America Holdings, 1120 Main Street, 
Southaven, MS 38671, 866-827-8042/800-233-6339 (Formerly: LabCorp 
Occupational Testing Services, Inc.; MedExpress/National Laboratory 
Center).
LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 
66219, 913-888-3927/800-873-8845 (Formerly: Quest Diagnostics 
Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division 
of LabOne, Inc.).
MedTox Laboratories, Inc., 402 W County Road D, St. Paul, MN 55112, 
651-636-7466/800-832-3244.
Legacy Laboratory Services--MetroLab, 1225 NE 2nd Ave., Portland, OR 
97232, 503-413-5295/800-950-5295.
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology 
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, 
testing for Veterans Affairs (VA) Employees Only.
National Toxicology Laboratories, Inc., 1100 California Ave., 
Bakersfield, CA 93304, 661-322-4250/800-350-3515.
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, 
TX 77504, 888-747-3774 (Formerly: University of Texas Medical Branch, 
Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory).
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 
91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology 
Laboratory).
Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, 
WA 99204, 509-755-8991/800-541-7891x7.
Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-635-
5840.
Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 30084, 
800-729-6432 (Formerly: SmithKline Beecham Clinical Laboratories; 
SmithKline Bio-Science Laboratories).
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 
610-631-4600/877-642-2216 (Formerly: SmithKline Beecham Clinical 
Laboratories; SmithKline Bio-Science Laboratories).
Redwood Toxicology Laboratory, 3700 Westwind Blvd., Santa Rosa, CA 
95403, 800-255-2159.
STERLING Reference Laboratories, 2617 East L Street, Tacoma, WA 98421, 
800-442-0438.
U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., 
Fort George G. Meade, MD 20755-5235, 301-677-7085, testing for 
Department of Defense (DoD) Employees Only.

    * The Standards Council of Canada (SCC) voted to end its Laboratory 
Accreditation Program for Substance Abuse (LAPSA) effective May 12, 
1998. Laboratories certified through that program were accredited to 
conduct forensic urine drug testing as required by U.S. Department of 
Transportation (DOT) regulations. As of that date, the certification of 
those accredited Canadian laboratories will continue under DOT 
authority. The responsibility for conducting quarterly performance 
testing plus periodic on-site inspections of those LAPSA-accredited 
laboratories was transferred to the U.S. HHS, with the HHS' NLCP 
contractor continuing to have an active role in the performance testing 
and laboratory inspection processes. Other Canadian laboratories 
wishing to be considered for the NLCP may apply directly to the NLCP 
contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 16, 
1996) as meeting the minimum standards of the Mandatory Guidelines 
published in the Federal Register on January 23, 2017 (82 FR 7920). 
After receiving DOT certification, the laboratory will be included in 
the monthly list of HHS-certified laboratories and participate in the 
NLCP certification maintenance program.

Charles P. LoDico,
Chemist.
[FR Doc. 2018-19074 Filed 8-31-18; 8:45 am]
 BILLING CODE 4162-20-P

44892 Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices

Terry Clark, Time: 8:00 a.m. to 6:00 p.m. DEPARTMENT OF HEALTH AND
Office of the Secretary, Asst. Paperwork Agenda: To review and evaluate grant HUMAN SERVICES
Reduction Act Reports Clearance Officer. applications.
[FR Doc. 2018–19084 Filed 8–31–18; 8:45 am] Place: The William F. Bolger Center, 9600 Substance Abuse and Mental Health
BILLING CODE 4151–AE–P Newbridge Drive, Potomac, MD 20854. Services Administration
Contact Person: Delia Tang, MD, Scientific
Review Officer, Research Programs Review Current List of HHS-Certified
DEPARTMENT OF HEALTH AND Branch, Division of Extramural Activities, Laboratories and Instrumented Initial
HUMAN SERVICES National Cancer Institute, NIH, 9609 Medical Testing Facilities Which Meet Minimum
Center Drive, Room 7W602, Bethesda, MD Standards To Engage in Urine Drug
National Institutes of Health 20892–9750, 240–276–6456, tangd@ Testing for Federal Agencies
mail.nih.gov.
National Cancer Institute; Notice of AGENCY: Substance Abuse and Mental
Name of Committee: National Cancer Health Services Administration, HHS.
Closed Meetings Institute Special Emphasis Panel; SEP–8: NCI
ACTION: Notice.
Pursuant to section 10(d) of the Clinical and Translational R21 and Omnibus
Federal Advisory Committee Act, as R03. SUMMARY: The Department of Health and
amended, notice is hereby given of the Date: November 1–2, 2018. Human Services (HHS) notifies federal
following meetings. Time: 6:00 a.m. to 4:00 p.m. agencies of the laboratories and
The meetings will be closed to the Agenda: To review and evaluate grant Instrumented Initial Testing Facilities
public in accordance with the applications. (IITF) currently certified to meet the
provisions set forth in sections Place: Bethesda Marriott Suites, 6711 standards of the Mandatory Guidelines
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Democracy Boulevard, Bethesda, MD 20817. for Federal Workplace Drug Testing
as amended. The grant applications and Contact Person: Reed A. Graves, Ph.D., Programs (Mandatory Guidelines).
the discussions could disclose Scientific Review Officer, Research A notice listing all currently HHS-
confidential trade secrets or commercial Technology and Contract Review Branch, certified laboratories and IITFs is
property such as patentable material, Division of Extramural Activities, National published in the Federal Register
and personal information concerning Cancer Institute, NIH, 9609 Medical Center during the first week of each month. If
individuals associated with grant Drive, Room 7W106, Bethesda, MD 20892–
any laboratory or IITF certification is
applications, the disclosure of which 9750, 240–276–6384, gravesr@mail.nih.gov.
suspended or revoked, the laboratory or
would constitute a clearly unwarranted Name of Committee: National Cancer IITF will be omitted from subsequent
invasion of personal privacy. Institute Special Emphasis Panel; HIV/AIDS lists until such time as it is restored to
and the Tumor Niche. full certification under the Mandatory
Name of Committee: National Cancer
Date: November 13, 2018. Guidelines.
Institute Special Emphasis Panel; SEP–6: NCI
Clinical and Translational R21 & Omnibus Time: 11:00 a.m. to 3:00 p.m. If any laboratory or IITF has
R03. Agenda: To review and evaluate grant withdrawn from the HHS National
Date: October 4, 2018. applications. Laboratory Certification Program (NLCP)
Time: 7:30 a.m. to 4:30 p.m. Place: National Cancer Institute, Shady during the past month, it will be listed
Agenda: To review and evaluate grant Grove, 9609 Medical Center Drive, Room at the end and will be omitted from the
applications. 7W618, Rockville, MD 20850 (Telephone
Place: Bethesda North Marriott Hotel &
monthly listing thereafter.
Conference Call). This notice is also available on the
Conference Center, 5701 Marinelli Road, Contact Person: Mukesh Kumar, Ph.D.,
Bethesda, MD 20852. internet at http://www.samhsa.gov/
Scientific Review Officer, Research Programs workplace.
Contact Person: Eduardo E. Chufan, Ph.D.,
Review Branch, Division of Extramural
Scientific Review Officer, Research FOR FURTHER INFORMATION CONTACT:
Technology and Contract Review Branch, Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W618, Charles LoDico, Division of Workplace
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Bethesda, MD 20892–9750, 240–276–6611, Programs, SAMHSA/CSAP, 5600
Drive, Room 7W254, Bethesda, MD 20892– mukesh.kumar3@nih.gov. Fishers Lane, Room 16N02C, Rockville,
9750, 240–276–7975, chufanee@mail.nih.gov. (Catalogue of Federal Domestic Assistance
Maryland 20857; 240–276–2600 (voice).
Name of Committee: National Cancer Program Nos. 93.392, Cancer Construction; SUPPLEMENTARY INFORMATION: The
Institute Special Emphasis Panel; SEP–9: NCI 93.393, Cancer Cause and Prevention Department of Health and Human
Clinical and Translational R21 and Omnibus Research; 93.394, Cancer Detection and Services (HHS) notifies federal agencies
R03. Diagnosis Research; 93.395, Cancer of the laboratories and Instrumented
Date: October 23, 2018. Initial Testing Facilities (IITF) currently
Treatment Research; 93.396, Cancer Biology
Time: 10:00 a.m. to 5:00 p.m.
Research; 93.397, Cancer Centers Support; certified to meet the standards of the
Agenda: To review and evaluate grant
applications. 93.398, Cancer Research Manpower; 93.399, Mandatory Guidelines for Federal
Place: National Cancer Institute, Shady Cancer Control, National Institutes of Health, Workplace Drug Testing Programs
Grove, 9609 Medical Center Drive, Room HHS) (Mandatory Guidelines). The Mandatory
7W114, Rockville, MD 20850 (Telephone Guidelines were first published in the
Dated: August 28, 2018.
Conference Call). Federal Register on April 11, 1988 (53
Contact Person: Jeffrey E. DeClue, Ph.D., Melanie J. Pantoja, FR 11970), and subsequently revised in
Scientific Review Officer, Research Program Analyst, Office of Federal Advisory the Federal Register on June 9, 1994 (59
Technology and Contract Review Branch, Committee Policy.
sradovich on DSK3GMQ082PROD with NOTICES

FR 29908); September 30, 1997 (62 FR
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
[FR Doc. 2018–19051 Filed 8–31–18; 8:45 am] 51118); April 13, 2004 (69 FR 19644);
Drive, Room 7W114, Bethesda, MD 20892– BILLING CODE 4140–01–P November 25, 2008 (73 FR 71858);
9750, 240–276–6371, decluej@mail.nih.gov. December 10, 2008 (73 FR 75122); April
Name of Committee: National Cancer 30, 2010 (75 FR 22809); and on January
Institute Initial Review Group; Subcommittee 23, 2017 (82 FR 7920).
I—Transition to Independence. The Mandatory Guidelines were
Date: October 24–25, 2018. initially developed in accordance with

VerDate Sep<11>2014 17:54 Aug 31, 2018 Jkt 244001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\04SEN1.SGM 04SEN1

Federal Register / Vol. 83, No. 171 / Tuesday, September 4, 2018 / Notices 44893

Executive Order 12564 and section 503 Dynacare,* 245 Pall Mall Street, Spokane, WA 99204, 509–755–8991/
of Public Law 100–71. The ‘‘Mandatory London, ONT, Canada N6A 1P4, 519– 800–541–7891x7.
Guidelines for Federal Workplace Drug 679–1630 (Formerly: Gamma- Phamatech, Inc., 15175 Innovation
Testing Programs,’’ as amended in the Dynacare Medical Laboratories). Drive, San Diego, CA 92128, 888–
revisions listed above, requires strict ElSohly Laboratories, Inc., 5 Industrial 635–5840.
standards that laboratories and IITFs Park Drive, Oxford, MS 38655, 662– Quest Diagnostics Incorporated, 1777
must meet in order to conduct drug and 236–2609. Montreal Circle, Tucker, GA 30084,
specimen validity tests on urine Laboratory Corporation of America 800–729–6432 (Formerly: SmithKline
specimens for federal agencies. Holdings, 7207 N Gessner Road, Beecham Clinical Laboratories;
To become certified, an applicant Houston, TX 77040, 713–856–8288/ SmithKline Bio-Science Laboratories).
laboratory or IITF must undergo three 800–800–2387. Quest Diagnostics Incorporated, 400
rounds of performance testing plus an Laboratory Corporation of America Egypt Road, Norristown, PA 19403,
on-site inspection. To maintain that Holdings, 69 First Ave., Raritan, NJ 610–631–4600/877–642–2216
certification, a laboratory or IITF must 08869, 908–526–2400/800–437–4986 (Formerly: SmithKline Beecham
participate in a quarterly performance (Formerly: Roche Biomedical Clinical Laboratories; SmithKline Bio-
testing program plus undergo periodic, Laboratories, Inc.). Science Laboratories).
on-site inspections. Laboratory Corporation of America Redwood Toxicology Laboratory, 3700
Laboratories and IITFs in the Holdings, 1904 TW Alexander Drive, Westwind Blvd., Santa Rosa, CA
applicant stage of certification are not to Research Triangle Park, NC 27709, 95403, 800–255–2159.
be considered as meeting the minimum 919–572–6900/800–833–3984 STERLING Reference Laboratories, 2617
requirements described in the HHS (Formerly: LabCorp Occupational East L Street, Tacoma, WA 98421,
Mandatory Guidelines. A HHS-certified Testing Services, Inc., CompuChem 800–442–0438.
laboratory or IITF must have its letter of Laboratories, Inc.; CompuChem U.S. Army Forensic Toxicology Drug
certification from HHS/SAMHSA Laboratories, Inc., a Subsidiary of Testing Laboratory, 2490 Wilson St.,
(formerly: HHS/NIDA), which attests Roche Biomedical Laboratory; Roche Fort George G. Meade, MD 20755–
that it has met minimum standards. CompuChem Laboratories, Inc., a 5235, 301–677–7085, testing for
In accordance with the Mandatory Member of the Roche Group). Department of Defense (DoD)
Guidelines dated January 23, 2017 (82 Laboratory Corporation of America
Employees Only.
FR 7920), the following HHS-certified Holdings, 1120 Main Street,
Southaven, MS 38671, 866–827–8042/ * The Standards Council of Canada
laboratories and IITFs meet the (SCC) voted to end its Laboratory
minimum standards to conduct drug 800–233–6339 (Formerly: LabCorp
Occupational Testing Services, Inc.; Accreditation Program for Substance
and specimen validity tests on urine Abuse (LAPSA) effective May 12, 1998.
specimens: MedExpress/National Laboratory
Center). Laboratories certified through that
HHS-Certified Instrumented Initial LabOne, Inc. d/b/a Quest Diagnostics, program were accredited to conduct
Testing Facilities 10101 Renner Blvd., Lenexa, KS forensic urine drug testing as required
66219, 913–888–3927/800–873–8845 by U.S. Department of Transportation
Dynacare, 6628 50th Street NW, (DOT) regulations. As of that date, the
Edmonton, AB Canada T6B 2N7, 780– (Formerly: Quest Diagnostics
Incorporated; LabOne, Inc.; Center for certification of those accredited
784–1190 (Formerly: Gamma- Canadian laboratories will continue
Dynacare Medical Laboratories). Laboratory Services, a Division of
LabOne, Inc.). under DOT authority. The responsibility
HHS-Certified Laboratories MedTox Laboratories, Inc., 402 W for conducting quarterly performance
County Road D, St. Paul, MN 55112, testing plus periodic on-site inspections
ACM Medical Laboratory, Inc., 160 of those LAPSA-accredited laboratories
Elmgrove Park, Rochester, NY 14624, 651–636–7466/800–832–3244.
Legacy Laboratory Services—MetroLab, was transferred to the U.S. HHS, with
844–486–9226. the HHS’ NLCP contractor continuing to
1225 NE 2nd Ave., Portland, OR
Alere Toxicology Services, 1111 Newton have an active role in the performance
97232, 503–413–5295/800–950–5295.
St., Gretna, LA 70053, 504–361–8989/ Minneapolis Veterans Affairs Medical testing and laboratory inspection
800–433–3823 (Formerly: Kroll Center, Forensic Toxicology processes. Other Canadian laboratories
Laboratory Specialists, Inc., Laboratory, 1 Veterans Drive, wishing to be considered for the NLCP
Laboratory Specialists, Inc.). Minneapolis, MN 55417, 612–725– may apply directly to the NLCP
Alere Toxicology Services, 450 2088, testing for Veterans Affairs (VA) contractor just as U.S. laboratories do.
Southlake Blvd., Richmond, VA Employees Only. Upon finding a Canadian laboratory to
23236, 804–378–9130 (Formerly: National Toxicology Laboratories, Inc., be qualified, HHS will recommend that
Kroll Laboratory Specialists, Inc., 1100 California Ave., Bakersfield, CA DOT certify the laboratory (Federal
Scientific Testing Laboratories, Inc.; 93304, 661–322–4250/800–350–3515. Register, July 16, 1996) as meeting the
Kroll Scientific Testing Laboratories, One Source Toxicology Laboratory, Inc., minimum standards of the Mandatory
Inc.). 1213 Genoa-Red Bluff, Pasadena, TX Guidelines published in the Federal
Baptist Medical Center—Toxicology 77504, 888–747–3774 (Formerly: Register on January 23, 2017 (82 FR
Laboratory, 11401 I–30, Little Rock, University of Texas Medical Branch, 7920). After receiving DOT certification,
AR 72209–7056, 501–202–2783 Clinical Chemistry Division; UTMB the laboratory will be included in the
(Formerly: Forensic Toxicology
sradovich on DSK3GMQ082PROD with NOTICES

Pathology-Toxicology Laboratory). monthly list of HHS-certified
Laboratory Baptist Medical Center). Pacific Toxicology Laboratories, 9348 laboratories and participate in the NLCP
Clinical Reference Laboratory, Inc., 8433 DeSoto Ave., Chatsworth, CA 91311, certification maintenance program.
Quivira Road, Lenexa, KS 66215– 800–328–6942 (Formerly: Centinela
2802, 800–445–6917. Hospital Airport Toxicology Charles P. LoDico,
DrugScan, Inc., 200 Precision Road, Laboratory). Chemist.
Suite 200, Horsham, PA 19044, 800– Pathology Associates Medical [FR Doc. 2018–19074 Filed 8–31–18; 8:45 am]
235–4890. Laboratories, 110 West Cliff Dr., BILLING CODE 4162–20–P

VerDate Sep<11>2014 17:54 Aug 31, 2018 Jkt 244001 PO 00000 Frm 00037 Fmt 4703 Sfmt 9990 E:\FR\FM\04SEN1.SGM 04SEN1

Document Created: 2018-09-01 02:59:31
Document Modified: 2018-09-01 02:59:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Charles LoDico, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857; 240-276-2600 (voice).
FR Citation		83 FR 44892

83 FR 44892 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICESSubstance Abuse and Mental Health Services Administration

Federal Register Volume 83, Issue 171 (September 4, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration